- Product Details
Keywords
- osimertinib mesylate
- 98.0%-102.0%
- Frontida
Quick Details
- ProName: osimertinib mesylate
- CasNo: 1421373-66-1
- Application: First-line treatment of patients with ...
- ProductionCapacity: Metric Ton/Day
- Purity: 98.0%-102.0%
- LimitNum: 0 Metric Ton
Superiority
Oxitinib is the third generation irreversible oral EGFR-TKI with central nervous system activity, which can effectively and selectively inhibit EGFR sensitive mutation and EGFR T790M drug-resistant mutation.